Clinical trials
Aortic Coarctation trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2010 | 2 |
| 2015 | 2 |
| 2019 | 1 |
| 2021 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Renata Medical | 2 |
| Boston Children's Hospital | 1 |
| Children's Healthcare of Atlanta | 1 |
| Emory University | 1 |
| Johns Hopkins University | 1 |
| Joshua Kanter | 1 |
| Mayo Clinic | 1 |
| Medical College of Wisconsin | 1 |
| Richard E. Ringel | 1 |
| University of California, San Francisco | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aortic Coarctation | 14 |
| Aortic Valve Stenosis | 2 |
| Stenosis, Pulmonary Artery | 2 |
| Cardiomegaly | 1 |
| Cardiomyopathies | 1 |
| Congenital, Hereditary, and Neonatal Diseases and Abnormalities | 1 |
| Ductus Arteriosus, Patent | 1 |
| Eye Abnormalities | 1 |
| Heart Defects, Congenital | 1 |
| Heart Septal Defects, Atrial | 1 |
Trials
Showing 26 to 14 of 14. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.